SFBC International
Company: SFBC International
Company Description: Dr. Lisa Krinsky is Chairman and President of SFBC International (Nasdaq: “SFCC”), a leading niche provider of drug development services to pharmaceutical and biotechnology companies. Under Dr. Krinksy’s leadership, SFBC has become one of the largest independent phase I/II CRO in North America and recognition as one of Fortune’s Magazine’s “Best 200 Small Companies in America” (#45).
Nomination Category: Individual Awards Categories
Nomination Sub Category: Best Executive
Nomination Title: Dr. Lisa Krinsky, President & Chairman
Tell the story about what this nominee achieved in 2003 (up to 500 words). Focus on specific accomplishments, and relate these accomplishments to past performance or industry norms. Be sure to mention obstacles overcome, innovations or discoveries made, and outcomes:
When Dr. Lisa Krinsky founded SFBC International, a provider of specialized drug
development services to branded pharmaceutical, biotechnology and generic drug
companies, in 1995, she only had a vision of what the Company could one day
become. At the time, there were only 6 employees and minimal revenue. She’s
brought this company a long way.Today, SFBC International is one of the fastest growing companies in the contract
research organization industry, with over 1,000 employees, and outstanding
financial results. In 2003, SFBC has reported that it anticipates revenue of
approximately $100 million, revenue growing at a CAGR of 82% since 1998 and
net income growing at a CAGR of 123% since 1998. The Company’s success is
based upon Dr. Krinsky’s commitment to building a well-rounded and well-
managed company that is driven by service and quality to its clients and
employees.One of the components of SFBC’s significant growth is Dr. Krinsky’s tremendous
dedication to SFBC’s clients. Paramount to the culture Dr. Krinsky has instilled
within her employees is the importance of client satisfaction, for both the drug
companies who hire SFBC and the participants whom SFBC recruits for studies.
Dr. Krinsky wants SFBC to be recognized as “The Plaza Hotel” of the CRO
industry. SFBC has a repeat client base of 85 percent and has been able to deliver
30 percent organic growth for the first nine months of 2003.Another element of SFBC’s significant growth can be attributed to the successful
acquisition strategy upon which Dr. Krinsky and her team have executed. In
August 2003, SFBC was proud to announce the acquisition of a company that had
previously been their largest local competitor in Miami.Dr. Krinsky is focused on ensuring that SFBC is well-positioned for the future. In
November 2003, SFBC completed a public equity offering with net proceeds of
almost $60 million that will be used for additional acquisitions and the continued
growth and development of its business.For the reasons highlighted above and many more, Dr. Krinsky was extremely
happy to learn that SFBC was ranked #3 on Forbes Magazine's list of "200 Best
Small Companies" in its October 27, 2003 issue, up from its #45 ranking in 2002.While 2003 has been SFBC’s most successful year since its founding, Dr.
Krinsky remains committed to delivering the highest quality results to her clients,
the best work environment to her employees and even greater value to
shareholders. This is one executive whose accomplishments imply that there will
be even more to come in the future.
List hyperlinks to any online news stories, press releases, or other documents that support the claims made in the section above. IMPORTANT: List each link on a separate line, begin each link with http://, and enclose each link in square brackets; for example, [http://www.website.com]:
Provide a brief (up to 100 words) biography about this nominee:
Dr. Lisa Krinsky (Founder of SFBC) is responsible for strategic planning,
developing and implementing new services, and establishing solid relationships of
confidence and respect with the firm’s growing client base. Her entrepreneurial
vision, based on concern for detail and commitment to excellence, has catapulted
the Company to become the largest independent phase I/phase II contract
research organization in North America.A specialist in investigative research and development operations, Dr. Krinsky has
spent 18 years in the clinical research industry developing new pharmaceutical
products. She founded South Florida Kinetics in 1995 became President and
Chairman of SFBC in 1999.